Results 151 to 160 of about 38,526 (184)

Bortezomib

Reactions Weekly, 2012
  +4 more sources

Bortezomib

Reactions Weekly, 2005
openaire   +2 more sources

Bortezomib

Reactions Weekly, 2011
openaire   +2 more sources

Bortezomib

Reactions Weekly, 2022
openaire   +2 more sources

Bortezomib

Reactions Weekly, 2016
  +6 more sources

Bortezomib

Reactions Weekly, 2013
  +4 more sources

Bortezomib

Reactions Weekly, 2018
  +4 more sources

Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial

Lancet, The, 2020
María-Victoria Mateos, Michele Cavo, Joan Bladé   +2 more
exaly  

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Lancet, The, 2020
Sebastian Grosicki, Ivan Spicka, Maria Gavriatopoulou   +2 more
exaly  

Bortezomib

Reactions Weekly, 2023
openaire   +1 more source